Literature DB >> 3082744

Limiting dilution analysis (LDA) of cells responding to recombinant interleukin-2 without previous stimulation: evidence that all responding cells are lymphokine-activated potent effectors.

H Vie, M Bonneville, P Sondermeyer, J F Moreau, J P Soulillou.   

Abstract

The relationship between peripheral blood mononucleated cells spontaneously bearing the IL-2 receptor (IL-2R) and cell cytotoxicity for the natural killer (NK)-sensitive K562 target cell line was investigated. For this purpose, three types of experiments were performed. (i) Positive selection of cells spontaneously bearing the IL-2R was carried out by culturing peripheral blood lymphocytes (PBL) in the sole presence of recombinant IL-2 (rIL-2). Cytotoxicity was assessed at Day 6 of the culture in a 4 hr cytotoxic assay. (ii) Negative selection was performed by complement mediated lysis using the B1.49.9 monoclonal antibody which is specific for the IL-2R. (iii) Limiting dilution analysis of non-adherent PBL was carried out in the presence of rIL-2 alone. The colonies obtained were divided and daughter colonies assayed for anti-K562 cytotoxicity in a 6 hr cytotoxic assay and for proliferation. The results show that: (i) a 6-day culture of human non-adherent PBL in the presence of rIL-2 alone leads to a sharp increase in anti-K562 cytotoxicity; (ii) depletion of B1.49.9 positive PBL strongly decreases cytotoxicity against K562 targets; (iii) limiting dilution analysis indicates that all colonies grown without activation in the presence of autologous serum and rIL-2 can mediate cytotoxicity against K562 targets, which is not the case when the starting population is activated. Thus, our data taken together strongly suggest that lymphocytes spontaneously bearing the IL-2R are directly involved in K562 lysis by fresh PBL (classical NK activity). Moreover, we demonstrate that all colonies able to proliferate without any activation, in the sole presence of rIL-2, are potent K562 killers (in this case, these cells correspond to the so-called lymphokine activated killers, LAK).

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3082744      PMCID: PMC1453821     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  17 in total

1.  Interleukin-2 augments natural killer cell activity.

Authors:  C S Henney; K Kuribayashi; D E Kern; S Gillis
Journal:  Nature       Date:  1981-05-28       Impact factor: 49.962

2.  Cytotoxic activities of normal cultured human T cells.

Authors:  J M Alvarez; M O de Landazuri; G D Bonnard; R B Herberman
Journal:  J Immunol       Date:  1978-10       Impact factor: 5.422

3.  The Fc receptor for IgG on human natural killer cells: phenotypic, functional, and comparative studies with monoclonal antibodies.

Authors:  B Perussia; G Trinchieri; A Jackson; N L Warner; J Faust; H Rumpold; D Kraft; L L Lanier
Journal:  J Immunol       Date:  1984-07       Impact factor: 5.422

4.  Ligand-activated T cell growth factor-induced proliferation: absorption of T cell growth factor by activated T cells.

Authors:  G D Bonnard; K Yasaka; D Jacobson
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

5.  Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T-cell growth factor.

Authors:  M T Lotze; E A Grimm; A Mazumder; J L Strausser; S A Rosenberg
Journal:  Cancer Res       Date:  1981-11       Impact factor: 12.701

6.  Induction of cytotoxic activity in human lymphocytes against autologous and allogeneic melanoma cells in vitro by culture with interleukin 2.

Authors:  P Hersey; C Bindon; A Edwards; E Murray; G Phillips; W H McCarthy
Journal:  Int J Cancer       Date:  1981-12       Impact factor: 7.396

7.  Cultured human T-cell lines kill autologous solid tumours.

Authors:  B M Vose; M Moore
Journal:  Immunol Lett       Date:  1981-10       Impact factor: 3.685

8.  Augmentation of human natural cell-mediated cytotoxicity by recombinant human interleukin 2.

Authors:  L P Svedersky; H M Shepard; S A Spencer; M R Shalaby; M A Palladino
Journal:  J Immunol       Date:  1984-08       Impact factor: 5.422

9.  THE EFFICIENT DESIGN OF TRANSPLANTABLE TUMOUR ASSAYS.

Authors:  E H PORTER; R J BERRY
Journal:  Br J Cancer       Date:  1963-12       Impact factor: 7.640

10.  Biochemical and biological characterization of lymphocyte regulatory molecules. V. Identification of an interleukin 2-producing human leukemia T cell line.

Authors:  S Gillis; J Watson
Journal:  J Exp Med       Date:  1980-12-01       Impact factor: 14.307

View more
  5 in total

1.  Stimulation of rheumatoid synovial and blood T cells and lines by synovial fluid and interleukin-2: characterization of clones and recognition of a co-stimulatory effect.

Authors:  N Hain; S Alsalameh; W M Bertling; J R Kalden; G R Burmester
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

2.  Phenotypic and functional characterization of T cells from patients with myasthenia gravis.

Authors:  F Mokhtarian; M Pino; W Ofosu-Appiah; D Grob
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

3.  Human immunodeficiency virus type 1 (HIV-1)-specific CD4+ T cells that proliferate in vitro detected in samples from most viremic subjects and inversely associated with plasma HIV-1 levels.

Authors:  Eli Boritz; Brent E Palmer; Cara C Wilson
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

4.  Interleukin-2 modulates the expression of lymphocyte function-associated antigen-one (LFA-1) and p150,95 during the generation of lymphokine-activated killer (LAK) cells.

Authors:  A J Grant; R E Merchant; R E Hall
Journal:  Immunology       Date:  1989-01       Impact factor: 7.397

5.  Characterization of IL-2 responsive synovial T lymphocytes in rheumatoid arthritis. II. Functional properties.

Authors:  W A Ofosu-Appiah; R J Warrington; J A Wilkins
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.